1Fe-LSD Micro 10mcg-300mcg

The distinct feature of this compound is the addition of a ferrocenecarbonyl moiety at the indole nitrogen. This ferrocene system – characterized by two cyclopentadienyl-bonded rings and a central iron atom – significantly alters the physical and structural properties of the derivative. This modification clearly separates 1Fe-LSD from regulated substance groups and opens the door to entirely new, legal experimental series.

The introduction of 1Fe-LSD Micropellets marks a complete generational shift in lysergamide analytics. Due to the ferrocene complex at the indole nitrogen, this product serves as a fully legally compliant substitute for the following, now illegal derivatives:

• 1S-LSD
• 1T-LSD
• 1D-LSD
• 1V-LSD
• 1B-LSD
• 1cP-LSD
• 1P-LSD
• ALD-52 (1A-LSD)

The micropellets guarantee precise molecular dosing, specifically calibrated to account for the increased molar mass of the ferrocene structure.

In chemical classification, 1Fe-LSD is categorized as a prodrug. For your research environment, this implies:

• The intact 1Fe-LSD molecule possesses little to no significant pharmacological binding affinity in-vitro.
• Conversion into the active base substance (LSD) occurs only in-vivo through endogenous enzymatic processes or chemical hydrolysis.
• This fundamental metabolism is already familiar to researchers from older analogs such as 1V-LSD, 1cP-LSD, or 1B-LSD.

Although 1Fe-LSD belongs to the same class of substances as 1P-LSD or 1D-LSD, early reports from our research groups show specific pharmacokinetic deviations:

• Metabolism: Data suggests an even faster enzymatic breakdown (shorter onset/rise) than its predecessor 1S-LSD.
• Universality: Despite the ferrocene group, 1Fe-LSD can be considered a full, identical substitute for formerly legal derivatives in most experimental setups.

A decisive factor when working with 1Fe-LSD is the Molar Mass. Due to the heavy iron atom (ferrocene), the molecule has a higher intrinsic weight than conventional lysergamide prodrugs. For comparative studies, the dose must therefore be precisely calibrated.

To offer researchers maximum flexibility, we provide the pellets in three precise concentrations. Based on current equivalence calculations, the following guide values apply:

Working with pressed pellets requires different laboratory routines than handling impregnated blotters. Please observe the following guidelines to maintain the chemical integrity of the 1Fe-LSD:

• Physical Stress (Abrasion): Unlike blotters, pellets can produce abrasion under heavy mechanical stress. Store containers in a vibration-free environment to avoid a loss of active ingredient precision due to dust formation.
• Climatic Conditions: Lysergamides exhibit high baseline stability. For regular laboratory operation, dry storage at room temperature is entirely sufficient.
• Handling Moisture: The pellets are not hygroscopic. If you prefer refrigerated storage for long-term studies, it is still mandatory to use airtight vessels (e.g., amber glass). Only open the vessel after full acclimation to room temperature to rule out condensation damage to the pellets.
• Contamination Protection: Wearing laboratory gloves is mandatory even with pellets. This serves less for self-protection and more to prevent the transfer of skin oils, which could distort subsequent in-vitro analysis of the tablet binders and the active ingredient.